64
THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

Embed Size (px)

Citation preview

Page 1: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION

SAMBIT MONDAL, MDCARDIAC ELECTROPHYSIOLOGIST

Page 2: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

AFLUTTER REVISITED

•AFLUTTER - RIGHT ATRIAL PRIMARILY

•AFIB - LEFT ATRIAL PRIMARILY

Page 3: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 4: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 5: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 6: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

Drug therapy vs first-line ablation for atrial flutter

61 patients> 1 episode of atrial flutterno prior antiarrhythmic drugtherapy

Antiarrhythmic DrugTherapysotalol, amiodaroneflecainide, procainamide,propafenone

RF Ablation> 90% reduction inelectrogram amplitudealong ablation line

Atrial Flutter Recurrence:

Atrial Fibrillation:

Sinus rhythm last f/u

93%

60%

36%

6%

29%

80%

mean follow-up: 22 months Natale et al J Am Coll Cardiol 2000

Page 7: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

CLASSIFICATION• Paroxysmal

• recurrent - at least 2 episodes

• terminates spontaneously within 1wk

• Persistent

• doesn’t terminate within 1wk or

• requires cardioversion to convert within 1wk

• Permanent / chronic

• > 1yr duration

Page 8: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

> 2.2 MILLION in USA have AFIB

Page 9: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 10: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

•AFFIRM TRIAL RACE TRIAL

N Engl J Med 2002; 347:1825-33 and 1834-40, Dec 5,2002

RATE VS RHYTHM CONTROL

Page 11: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

AFFIRM- efficacy of antiarrhythmics

Page 12: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

AFFIRM TRIAL•3/4 normal EF

•Mortality difference mainly due to non-cardiovascular and cancer deaths

•No difference in the rate of cardiovascular events - including stroke.

• Presence of sinus rhythm reduced mortality significantly, however anti-arrhythmics seemed to increase mortality by 49% : beneficial effects of SR may be offset by anti-arrhythmics

•DIAMOND study confirmed the above hypothesis.

Page 13: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

OPTIONS FOR RATE CONTROL

•MEDICATIONS

•AV NODAL ABLATION

•last option

•doesn’t eliminate symptoms of afib

•permanent dependancy on PM

•6.3% 1-yr mortality : 2% risk of SCD

•BiV vs single chamber pacing ( PAVE )

Page 14: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

so which is better ?rhythm or rate

control

Page 15: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PROVEN DATA

•independent predictor of mortality

•valvular heart disease

•post CABG

•heart failure

•decrease survival

Page 16: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

RHYTHM CONTROL•quality of life improved significantly

with rhythm

•mortality data not available

•stroke risk data pending long term studies

•progression to heart failure decreased by rhythm control

•hospital admission / overall cost reduced by rhythm control

Page 17: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

NATURAL HISTORY

paroyxsmal

lone fib

perst/perm

50%

40%

CATH ABLATIONSINUS RHYTHM

Heart rhythm Pappone et al. Nov 08:5:11:1501-1507

Page 18: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

RACE FOR A CURE

•THE HOLY GRAIL

Page 19: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PATHOPHYSIOLOG

Y•multiple wavelet theory Moe et al. 1980’s

•multiple reentrant circuits which requires critical mass of atrial tissue to sustain itself

•basis for cut and sew Cox-Maze procedure to reduce critical mass

• version I, II and now III

•atrial transport function

•difficult to perform - didn’t gain popularity

Page 20: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 21: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 22: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 23: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 24: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 25: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

2003/2004 Pappone et al.

Page 26: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PATHOPHYSIOLOGY

•cardiac autonomic nervous system and its relationship with triggered spontaneous electrical firing - Jackman et al.

•current understanding of triggers, rotors, substrate and autonomic interactions

Page 27: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 28: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 29: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PATHOPHYSIOLOGY• atrial muscle sleeve into the pulmonary veins

as trigger sites

• APD and ERP within the pulmonary veins shorter than LA tissue

• slower conduction of tissue towards atrio-pulmonary junction leading to variable block and micro re-entry.

• areas of slower conduction marked as fractionated potentials

• more fractionation seen with increased in LA pressures

Page 30: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PATHOPHYSIOLOGY•areas of micro-reentry at the sites of

slowed conduction : rotors at LA-PV

•not clear what causes triggered activity within pulmonary veins

•atrial remodelling : “afib begets afib”

•LA-RA electrical heterogeneity and gradient

Page 31: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PATHOPHYSIOLOGY

•spectral analysis : dominant frequency stimulation sites within pulmonary veins in paroxysmal afib.

•chronic afib: no dominant frequency seen.

•chronic afib: atrial remodelling plays a more dominant role

Page 32: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PATHOPHYSIOLOGY

•nearly 1/3 paroxysmal ( unselected population) : non PV triggers

•non PV triggers : post LA, fossa ovalis, SVC, crista terminalis, ligament of Marshall, AV junction, coronary sinus

•4% SVT initiating Afib : AVNRT, AVRT

Page 33: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

PAROXYSMAL AFIB PERSISTENT / CHRONIC AFIB

antiarrhythmicscardioversion with antiarrhythmics

feel better in SR no difference

rhythm control

rhythm control with meds only and if not possible then RATE

CONTROL

recurrence

Page 34: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

RHYTHM CONTROL SCHEMA

ACC/AHA/HRS GUIDELINE UPDATE FOR MANAGEMENT OF AFIB 2006

MAINTAINENCE OF SINUS RHYTHM

AMIODARONEDOFETILIDE

ABLATION

FLECAINIDEPROPAFENONE

SOTALOL

NO HEART DISESE

ABLATION

AMIODARONE

SUBSTANTIAL LVH

AMIODARONE ABLATION

SOTALOLDOFETILIDE

CAD

ABLATION

AMIODARONEDOFETILIDE

HEART FAILURE

Page 35: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

ANTICOAGULATION• CHADS 2 RISK SCORE:

• Congestive heart failure

• Hypertension

• Age greater than 75

• Diabetes Mellitus

• Stroke or any thromboembolic phenomenon

CHADS SCORE

0 - ASA

1- ASA OR COUMADIN

>1 or high risk markers COUMADIN

Page 36: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

ABLATIVE OPTIONS

•CATHETER BASED

•SURGICAL - CONCOMITANT

•SURGICAL STAND ALONE

• “MINI MAZE”

Page 37: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

INDICATIONS

•SYMPTOMS

•FAILED ≥ 1 ANTIARRHYTHMIC

•EF >40%

•AGE < 80 YRS

Page 38: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

SYMPTOMS

•fatigue “sleeps off as soon as lay on the couch in the evenings” - under-recognized

•dyspnea on exertion

•palpitations “heart skipping”

•chest pain

•“just don’t feel right”

Page 39: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

CATHETER ABLATION

•It is not a substitute for coumadin therapy and to attempt ablation aiming primarily at stopping coumadin therapy is INAPPROPRIATE

•All patients will continue coumadin therapy post ablation

•IT IS NOT A CURE, BUT A TREATMENT APPROACH - much akin to CAD/stent.

•applies to surgical ablation also

Page 40: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

SUCCESS RATES

•PAROXYSMAL AFIB : > 70-80%

•PERSISTENT AFIB : >60-70%

•CHRONIC AFIB : 50-60%

•SUCCESS AT 6MONTHS

•POST PROCEDURE RECURRENCE OF ARRHYTHMIA IS COMMON AND NOT A SIGN OF FAILURE - atrial remodelling 3months

Page 41: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 42: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

QuickTime™ and aMotion JPEG OpenDML decompressor

are needed to see this picture.

Page 43: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

QuickTime™ and aMotion JPEG OpenDML decompressor

are needed to see this picture.

Page 44: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

QuickTime™ and aMotion JPEG OpenDML decompressor

are needed to see this picture.

Page 45: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 46: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 47: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

CFAE MAPS•complex fractionated atrial electrogram

•0.06 - 0.25V, >120ms

•represent areas of slow conduction / micro-reentry

•correlate with epicardial ganglionic plexi

•important in persistent and chronic cases

Page 48: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

ICE

•intracardiac echo imaging

•5.5-10MHz, depth 2-12mm

•transeptal puncture, defining LA structures, pulmonary vein anatomy, location of circular catheter, complication detection and management

Page 49: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

QuickTime™ and aMotion JPEG OpenDML decompressor

are needed to see this picture.

Page 50: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

POST ABLATION•follow up

•2wk - 12 lead EKG

•1month - 24 hour holter

•3months - 1 month AFib monitor ( decision to take off antiarrythmics)

•6month - 1 month Afib monitor ( decision to take off coumadin if CHADS score <2)

Page 51: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

RECURRENCE• recurrences of atrial fibrillation / atrial tachycardia / left atrial

or right atrial flutter

• recurrences more common within the 1-3month period

• inflammatory / stimulating effect of thermal injury

• imbalance of autonomic nervous system

• delayed effect of growth and maturation of lesions

• factors favoring recurrences

• age

• BMI

• paroxysmal vs persistent vs chronic

• size of left atrium

• structural heart disease

Page 52: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

RECURRENCE

•reconnection PV-LA

•additional triggers

•macro-reentrant tachycardia

•autonomic influences

Page 53: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

COMPLICATION• cardiac tamponade - upto 3%

• pulmonary vein stenosis - 1-3%

• chest pain / dyspnea / recurrent lung infection / pulmonary hypertension

• atrio-esophageal fistula - 0.25%

• fever / chills / hemoptysis / recurrent neurological events

• phrenic nerve injury - <0.5%

• hiccups / dyspnea / atelectasis / pleural effusion / cough / thoracic pain

• Thromboembolic events / air embolism / stroke

• vascular complication

• acute coronary occlusion

• peri-esophageal vagal injury - pyloric spasm / gastric hypomotility

• fluroscopy related injury

• mitral valve entrapment of circular catheter

Page 54: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

SURGICAL ABLATION

Page 55: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

COX MAZE• James Cox 1987

• extensive cut and sew to interrupt the reentrant circuits

• technically challenging and time taking

• long term success rates good however few CT surgeon willing to perform the full cut and sew Maze

• numerous iteration have been developed. Final version Cox Maze III.

• linear lines of ablation developed with unipolar sources of energy

Page 56: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

ENERGY SOURCES

•unipolar energy source

•microwave / radiofrequency / HIFU / cryo / laser

•bipolar energy source

•radiofrequency

Page 57: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

SURGICAL ABLATION

•full Cox Maze procedure ( Maze III )

•LA ablation sets

•pulmonary vein isolation

Page 58: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

SURGICAL ABLATION•INDICATIONS:

•concomitant procedure - both symptomatic and asymptomatic patients

•stand alone minimally invasive ( mini Maze)

•prefer surgical approach

•failed one or more attempts at catheter ablation

•not candidates for catheter ablation

Page 59: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

Mini - Maze

Page 60: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

multi-speciality approach

•primary care physicians

•cardiologist

•cardiac electrophysiologist

•cardio-thoracic surgeons

Page 61: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 62: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 63: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST
Page 64: THERAPUETIC OPTIONS FOR AFIB: CATHETER ABLATION SAMBIT MONDAL, MD CARDIAC ELECTROPHYSIOLOGIST

“Watchman” left atrial occluding device

Maisel W. N Engl J Med 2009;10.1056/NEJMp0903763